Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model

Journal of Infectious Diseases

Volumn 209, Issue 9, 2014, Pages 1354-1361

  Huang, Kuan Ying Arthur ^a,b   Li, Chris Ka Fai ^a   Clutterbuck, Elizabeth ^c   Chui, Cecilia ^a   Wilkinson, Tom ^d   Gilbert, Anthony ^e   Oxford, John ^e   Lambkin Williams, Rob ^e   Lin, Tzou Yien ^b,f   Mcmichael, Andrew J ^a   Xu, Xiao Ning ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e Retroscreen Virology   (United Kingdom)

^f CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

B cells; human challenge model; influenza A virus

Indexed keywords

B CELLS; HUMAN CHALLENGE MODEL; INFLUENZA A VIRUS;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, CD27; B-LYMPHOCYTES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MODELS, IMMUNOLOGICAL; VIRAL LOAD; YOUNG ADULT;

EID: 84898849416     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit650     Document Type: Article

References (31)

1. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199-202
2. Wrammert J, Koutsonanos D, Li GM, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181-93
3. Odendahl M, Mei H, Hoyer BF, et al. Generation of migratory antigenspecific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005; 105:1614-21
4. Mei HE, Yoshida T, Sime W, et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009; 113:2461-9
5. Halliley JL, Kyu S, Kobie JJ, et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010; 28:3582-7
6. Mathew A, West K, Kalayanarooj S, et al. B-Cell responses during primary and secondary dengue virus infections in humans. J Infect Dis 2011; 204:1514-22
7. Buckner CM, Moir S, Ho J, et al. Characterization of plasmablasts in the blood of HIV-infected viremic individuals: Evidence for non-specific immune activation. J Virol 2013; 87:5800-11
8. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010; 328:745-8
9. Wrammert J, Onlamoon N, Akondy RS, et al. Rapid and massive virusspecific plasmablast responses during acute dengue virus infection in humans. J Virol 2012; 86:2911-8
10. Li GM, Chiu C, Wrammert J, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci USA 2012; 109:9047-52
11. Klenovsek K, Weisel F, Schneider A, et al. Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007; 110:3472-9
12. Narvaez CF, Feng N, Vasquez C, et al. Human rotavirus-specific IgM memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo. J Virol 2012; 86:10829-40
13. Fondere JM, Huguet MF, Yssel H, et al. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. AIDS 2003; 17:2323-30
14. Jaimes MC, Rojas OL, Kunkel EJ, et al. Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children. J Virol 2004; 78:10967-76
15. Hobson D, Curry RL, Beare AS, Wardgard A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972; 70:767-77
16. Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody Titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30:1081-5
17. Wang M, Yuan J, Li T, et al. Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China. PLOS One 2011; 6:e16809
18. Song JY, Cheong HJ, Hwang IS, et al. Long-Term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 2010; 28:3929-35
19. Bedognetti D, Zoppoli G, Massucco C, et al. Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol 2011; 186:6044-55
20. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011; 121:3109-19
21. Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012; 18:274-80
22. Wu J, Zhong X, Li CK, et al. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 2011; 29:1009-16
23. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigenspecific memory B cells: A sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286:111-22
24. Pinna D, Corti D, Jarrossay D, Sallusto F, Lanzavecchia A. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 2009; 39:1260-70
25. Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509-16
26. Wrammert J, Smith K, Miller J, et al. Rapid cloning of high-Affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71
27. Frölich D, Giesecke C, Mei HE, et al. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol 2010; 185:3103-10
28. Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLOS One 2008; 3:e2975
29. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: Long-Term B cell memory in humans after smallpox vaccination. J Immunol 2003; 171:4969-73
30. Blanchard-Rohner G, Galli G, Clutterbuck EA, Pollard AJ. Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children. J Immunol Methods 2010; 358:46-55
31. Galli G, Hancock K, Hoschler K, et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci USA 2009; 106:7962-7.